secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEAYA Biosciences, Inc. (IDYA)
CIK:        0001676725
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001193125-25-151257
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

IDEAYA Biosciences appoints Joshua Bleharski as CFO
---------------------------------------------------

- Joshua Bleharski, Ph.D. appointed CFO and Principal Financial Officer effective June 26, 2025.
- Appointment made by Board of Directors; no departure of prior CFO or compensation disclosed.
- Bleharski assumes responsibilities as CFO; no other leadership changes announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676725/000119312525151257/0001193125-25-151257-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676725/000119312525151257/d28084d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-151257

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer